MAM
VRCA icon

Meeder Asset Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Meeder Asset Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-415
Closed -$47K – 2652
2021
Q2 		$47K Buy
+415
New +$50.3K ﹤0.01% 1152
2020
Q4 		– Sell
-63
Closed -$5K – 2247
2020
Q3 		$5K Sell
63
-6
-9% -$492 ﹤0.01% 1601
2020
Q2 		$8K Sell
69
-323
-82% -$37.4K ﹤0.01% 1399
2020
Q1 		$42K Sell
392
-38
-9% -$5K ﹤0.01% 977
2019
Q4 		$69K Buy
+430
New +$63.5K ﹤0.01% 919

Other funds holding VRCA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return